FASN and colorectal cancer: Surprisingly, however, there is still no direct experimental evidence for this intuitive idea other than a single recent study, which showed that colorectal cancer cells exposed to the FASN inhibitor TVB-3664 import large amounts of dietary lipids via the FA receptor and transporter protein CD36 to alleviate their lipid shortage (13).